Description
The antibody H103 in specific binding with hypoxic liver cancer cells is successfully cloned from the self-established human phage single-chain antibody library. The antibody may can be used in diagnosis and targeted therapy on the hypoxic phenotype liver tumor.
Target
Hypoxic Liver Cancer
Isotype/Mimetic
Human IgG
Animal-Derived Biomaterials Used
None
Sequence Available
No
Original Discovery Method
Human-derived phage display
Original Discovery Information Provided On Datasheet
No
Antibody/Binder Origins
Animal-free discovery, In vitro recombinant expression